Trends in cancer mortality in Switzerland, 1980-2001

European Journal of Cancer Prevention

Volumn 15, Issue 1, 2006, Pages 1-9

  Levi, Fabio ^a,d   Lucchini, Franca ^a   La Vecchia, Carlo ^a,b,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Registre Vaudois des Tumeurs   (Switzerland)

Author keywords

Cancer; Mortality; Switzerland; Time trends

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CARCINOMA; CANCER MORTALITY; CHILD; COLORECTAL CARCINOMA; CONTROLLED STUDY; DATA BASE; FEMALE; HODGKIN DISEASE; HUMAN; INFANT; LEUKEMIA; LUNG CARCINOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOMA; NEWBORN; PRIORITY JOURNAL; SEX RATIO; STANDARDIZATION; STOMACH CARCINOMA; SWITZERLAND; TESTIS CARCINOMA; TOBACCO; UTERUS CARCINOMA; WORLD HEALTH ORGANIZATION;

ADULT; AGE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; SEX DISTRIBUTION; SWITZERLAND;

EID: 30044444654     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cej.0000186638.35119.88     Document Type: Article

References (52)

1. Bolla M, Gonzalez D, Werde P, Dubois JB, Mirimanoff RO, Storme G, et al. (1999). Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337:295-300.
2. Bosetti C, Negri E, Trichopoulos D, Franceschi S, Beral V, Tzonou A, et al. (2002). Long-term effects of oral contraceptives on ovarian cancer risk. Int J Cancer 102:262-265.
3. Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F (2004). Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res 14:301-309.
4. Boyle P (2004). Testicular cancer: the challenge for cancer control. Lancet Oncol 5:56-61.
5. Boyle P (2005). Tobacco smoking and the British doctors' cohort. Br J Cancer 92:419-420.
6. Boyle P, Autier P, Bartelink H, Baselga J, Boffetta P, Burn J, et al. (2003). European Code Against Cancer and scientific justification: third version (2003). Ann Oncol 14:973-1005.
7. Bulliard JL, De Landtsheer JP, Levi F (2003). Results from the Swiss mammography screening programme. Eur J Cancer 39:1761-1769.
8. Corrao G, Bagnardi V, Zambon A, La Vecchia C (2004). A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38:613-619.
9. Cuzick J (1994). Multiple myeloma. Cancer Surv 19/20:455-474.
10. De Vries E, Bray F, Coebergh JWW, Parkin DM, for the European Network of Cancer Registries (2003). Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer 107:119-126.
11. Doll R, Smith PG (1982). Comparison between registries: age-standardized rates. In: Waterhouse JAH, Muir CS, Shanmugaratnam K, Powell J, Peacham D, Whelan S, (editors). Cancer incidence in five continents, Vol. IV. IARC Scientific Publication No 42. Lyon: International Agency for Research on Cancer; pp. 671-675.
12. Doll R, Peto R, Boreham J, Sutherland I (2005). Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 92:426-429.
13. Early Breast Cancer Trialists' Collaborative Group (1998a). Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 361:1451-1467.
14. Early Breast Cancer Trialists' Collaborative Group (1998b). Polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet 352:930-942.
15. Fernandez E, La Vecchia C, Gonzalez JR, Lucchini F, Negri E, Levi F (2005). Converging patterns of colorectal cancer mortality in Europe. Eur J Cancer 14:973-1005.
16. Fisher B, Jeong J-H, Anderson S, Wolmark N (2004). Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project Clinical Trials. J Natl Cancer Inst 96:1823-1831.
17. Garattini S, La Vecchia C (2001). Perspectives in cancer chemotherapy. Eur J Cancer 37(suppl 8):S128-S147.
18. Gutjahr E, Gmel G (2005). Association of alcohol consumption to mortality and person-years of life lost in Switzerland. Measuring the impact of some methodological options. Eur J Epidemiol 20:37-47.
19. Hsing AW, Tsao L, Devesa S (2000). International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85:60-67.
20. Institut suisse de prévention de l'alcoolisme et autres toxicomanies (ISPA/SFA) (1999). Chiffres et données sur l'alcool et les autres drogues 1999. Berne: Institut suisse de prévention de l'alcoolisme et autres toxicomanies, p. 76.
21. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 83. Lyon: International Agency for Research on Cancer.
22. La Vecchia C, Levi F, Decarli A, Wietlisbach V, Negri E, Gutzwiller F (1988). Trends in smoking and lung cancer mortality in Switzerland. Prev Med 17:712-724.
23. La Vecchia C, Lucchini F, Franceschi S, Negri E, Levi F (2000). Trends in mortality from primary liver cancer in Europe. Eur J Cancer 36:909-915.
24. La Vecchia C, Lucchini F, Negri E, Levi F (2004). Trends in oral cancer mortality in Europe. Oral Oncol 40:433-439.
25. Levi F, La Vecchia C, Randimbison L (1997). Cancer mortality in Switzerland, 1990-1994. Soz Praventivmed 42:37-54.
26. Levi F, La Vecchia C, Boyle P (2000a). The rise and fall of prostate cancer. Eur J Cancer Prev 9:381-385.
27. Levi F, Lucchini F, Negri E, Barbui T, La Vecchia C (2000b). Trends in mortality from leukaemia in subsequent age groups. Leukemia 14:1980-1985.
28. Levi F, Lucchini F, Negri E, Franceschi S, La Vecchia C (2000c). Cervical cancer mortality in young women in Europe: patterns and trends. Eur J Cancer 36:2266-2271.
29. Levi F, Lucchini F, Negri E, La Vecchia C (2001). The fall in breast cancer mortality in Europe. Eur J Cancer 37:1409-1412.
30. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C (2002a). Trends in mortality from Hodgkin's disease in western and eastern Europe. Br J Cancer 87:291-293.
31. Levi F, Lucchini F, Negri E, La Vecchia C (2002b). Trends in mortality from non-Hodgkin's lymphomas. Leuk Res 26:903-908.
32. Levi F, Lucchini F, Boyle P, Negri E, La Vecchia C (2003a). Testicular cancer mortality in eastern Europe. Int J Cancer 103:574.
33. Levi F, Lucchini F, Negri E, La Vecchia C (2003b). The end of the tobacco-related lung cancer epidemic in Europe. J Natl Cancer Inst 95:631-632.
34. Levi F, Lucchini F, Negri E, La Vecchia C (2003c). The recent decline in gallbladder cancer mortality in Europe. Eur J Cancer Prev 12:265-267.
35. Levi F, Lucchini F, Gonzalez JR, Fernandez E, Negri E, La Vecchia C (2004a). Monitoring falls in gastric cancer mortality in Europe. Ann Oncol 15:338-345.
36. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C (2004b). Cancer mortality in Europe, 1995-99, and an overview of trends since 1960. Int J Cancer 110:155-169.
37. Levi F, Lucchini F, Negri E, La Vecchia C (2004c). Trends in mortality from major cancers in the European Union, including acceding countries, in 2004. Cancer 101:2843-2850.
38. Levi F, Lucchini F, Negri E, Zatonski W, Boyle P, La Vecchia C (2004d). Trends in cancer mortality in the EU and accession countries, 1980-2000. Ann Oncol 154:1425-1431.
39. Lutz JM, Pury P, Fioretta G, Raymond L (2004). The impact of coding process on observed cancer mortality trends in Switzerland. Eur J Cancer Prev 13:77-81.
40. Melia J, Pendry L, Eisr JR, Harland C, Moss S (2000). Evaluation of primary prevention initiatives for skin cancer: a review from a UK perspective. Br J Dermatol 143:701-708.
41. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D (1999). Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341:1781-1788.
42. Muss HB, Woolf S, Berry D, Cirrincione C, Weiss RB, Budman D et al., for the Cancer and Leukemia Group B (2005). Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293:1073-1081.
43. Naldi L, Imberti GL, Parazzini F, Gallus S, La Vecchia C (2000). GISED. Pigmentary traits, modality of sun reactions, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population. Results of a collaborative case-control study. Cancer 88:2703-2710.
44. Negri E, La Vecchia C (2001). Epidemiology and prevention of bladder cancer. Eur J Cancer Prev 10:7-14.
45. Pelucchi C, Malvezzi M, La Vecchia C, Levi F, Decarli A, Negri E (2004). The mesothelioma epidemic in Western Europe: an update. Br J Cancer 8:1022-1044.
46. Peto J, Gilham C, Fletcher O, Matthews FE (2004). The cervical cancer epidemic that screening has prevented in the UK. Lancet 364:249-256.
47. Tarone RE, Chu KC, Brawley OW (2000). Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates. Epidemiology 11:167-170.
48. Weir HK, Thun MJ, Hankey BF, Ries LAG, Howe HL, Wingo PA et al. (2003). Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95:1276-1299.
49. World Health Organization (1967). International Classification of Disease: 8th revision. Geneva: World Health Organization.
50. World Health Organization (1992). International Statistical Classification of Disease and Related Health Problems. 10th revision. Geneva: World Health Organization.
51. World Health Organization (1997). Tobacco or health: a Global Status Report. Geneva: World Health Organization.
52. World Health Organization Statistical Information System (2004). WHO mortality database: http://www3.who.int/whosis/menu.cfm. Geneva: World Health Organization.